ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

NEJM Paper: Ownership of IMRT Centers Prompts Urologists to Refer Patients to Radiation Therapy

October 25, 2013

Reports On Nutrition & Cancer Show Needs For More Clinical Studies

September 5, 1975

In Brief: Money Bill Delay Seen Until After Election ACCC Meeting Planned On Community Programs

September 15, 1978

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012

Senate Bill Matches 42.01 Billion Bush request For NCI, Sets Bypass Funding For Breast Cancer

September 18, 1992